- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2008
- Public Summary Document (PSD) July 2008 PBAC Meeting - PDF
Adalimumab – July 2008
Adalimumab, injection, 40 mg in 0.8 mL pre-filled syringe, 40 mg in 0.8 mL pre-filled pen, Humira®, July 2008
Last updated
14 November 2008